Meditrix Co., Ltd.

Meditrix Co. , Ltd. is a Tokyo-based company that specializes in optimizing Real World Data Value through clinical research and post-marketing surveillance studies, enhancing data management in the medical device sector. Founded in 2012 and headquartered in Tokyo, Japan, Meditrix Co.

, Ltd. focuses on clinical research and data management services. The company has remained consistent in its business strategy since inception, emphasizing collaboration with healthcare institutions and pharmaceutical companies to improve research efficacy. Meditrix Co.

, Ltd. specializes in providing a comprehensive suite of services aimed at optimizing Real World Data Value through various clinical research initiatives and post-marketing surveillance (PMS) studies. The company offers specialized services such as data collection support for PMS and clinical research, including assistance with Case Report Form (CRF) completion and Electronic Data Capture (EDC) input. Their service portfolio is designed to support healthcare institutions by streamlining research processes and enhancing data management efficiency.

Meditrix primarily serves clients in the medical device sector, leveraging its extensive project experience to cater to hospitals and clinical research sites across Japan, particularly in regions such as Kanto, Kansai, and Kyushu. Meditrix Co. , Ltd. generates revenue through a structured transaction model that encompasses service contracts primarily with healthcare institutions and pharmaceutical companies.

The pricing framework is typically aligned with the specific services offered, such as project-based fees for clinical trial support, ongoing contracts for data management, and subscription models for their proprietary digital health systems. Clients engage in direct partnerships for tailored services, ensuring that their research needs are met efficiently. The revenue streams are diversified, stemming from clinical research support, monitoring services, and data analytics, which together enhance the company's financial stability. Meditrix Co.

, Ltd. aims to innovate its service offerings by developing new digital health tools in 2024, enhancing its data collection capabilities. The company plans to expand its operations into the Asian markets, targeting regions such as Southeast Asia by 2025 to broaden its client base. Recent funding will support these initiatives by facilitating technology development and market entry efforts.